Valuation: Sopharma AD

Market Cap 1.97B 1.18B 1.01B 946M 868M 1.63B 113B 1.66B 11.16B 4.37B 56.61B 4.43B 4.34B 187B P/E 2024
12.3x
P/E 2025 7.16x
Enterprise Value 2.51B 1.51B 1.29B 1.21B 1.11B 2.08B 144B 2.12B 14.23B 5.57B 72.19B 5.65B 5.53B 239B EV / Sales 2024
0.66x
EV / Sales 2025 0.76x
Free-Float
31.06%
Yield 2024
2.68%
Yield 2025 -
1 day-0.26%
1 week+0.26%
Current month+0.26%
1 month+2.12%
3 months+4.89%
6 months+0.26%
Current year+35.48%
1 week 1.91
Extreme 1.91
1.94
1 month 1.84
Extreme 1.845
1.94
Current year 1.41
Extreme 1.41
2
1 year 1.24
Extreme 1.242707
2
3 years 0.94
Extreme 0.940394
2
5 years 0.58
Extreme 0.581414
2
10 years 0.41
Extreme 0.408688
2
Manager TitleAgeSince
Chief Executive Officer 42 30/09/2000
Director of Finance/CFO - 31/12/2001
Chief Administrative Officer - -
Director TitleAgeSince
Chairman 42 18/05/2010
Director/Board Member 63 18/05/2010
Director/Board Member 61 11/07/2011
Date Insider Type Main position Quantity % Market Cap.
30/09/20
Donev Investments Ad
BuyCompany 25,489 0.0189%
30/09/20 Buy

Chief Executive Officer

12,000 0.0089%
29/09/20
Donev Investments Ad
BuyCompany 9,000 0.0067%
Change 5-day change 1-year change 3-year change Capi.($)
-0.26%+0.26%+53.54%+98.01% 1.18B
+1.04%-1.37%-41.42%-5.47% 15.65B
0.00%-10.21%-41.03%-25.17% 6.71B
+1.35%-1.39%-18.94%-13.75% 6.13B
-0.13%-2.72%+0.42%-24.31% 4.31B
+0.05%-3.38%-18.99%-40.23% 3.22B
0.00%-5.04%+4.55%-36.71% 3.02B
+0.16%-2.83%-43.17%-22.92% 3.01B
-0.86%-0.86%-13.07%-4.14% 2.61B
-1.35%-2.13%+48.66% - 2.42B
Average 0.00%-2.39%-6.94%-8.30% 4.83B
Weighted average by Cap. +0.39%-3.03%-22.12%-14.14%

Financials

2024 2025
Net sales 2.14B 1.28B 1.1B 1.03B 944M 1.78B 123B 1.8B 12.14B 4.76B 61.6B 4.82B 4.72B 204B 2.63B 1.58B 1.36B 1.27B 1.16B 2.19B 151B 2.22B 14.94B 5.85B 75.8B 5.94B 5.81B 251B
Net income 77.85M 46.75M 40.11M 37.45M 34.36M 64.61M 4.47B 65.68M 442M 173M 2.24B 176M 172M 7.41B 134M 80.19M 68.79M 64.23M 58.93M 111M 7.66B 113M 758M 297M 3.84B 301M 295M 12.71B
Net Debt 444M 267M 229M 214M 196M 369M 25.5B 375M 2.52B 987M 12.79B 1B 980M 42.28B 541M 325M 279M 260M 239M 449M 31.07B 457M 3.07B 1.2B 15.58B 1.22B 1.19B 51.53B
Logo Sopharma AD
Sopharma AD, formerly Sopharma AD Sofia, is a Bulgaria-based company engaged in the generic pharmaceutical industry. The Company specializes in the production and trade of medical substances and finished drug forms, as well as research and development in the field of medical products. Through the ampoule plant, tablet plant and the plant in Vrabevo it produces medicines, such as analgesics, antipyretics, cardiovascular medicines as well as drugs for respiratory disease treatment, among others. The Company offers its products under the brand Tribestan, Nivalin and Tabex, among others. In addition, it specializes in the gamma-sterilization of medical materials. It is the parent company of Sopharma Group and operates domestically and abroad in such countries as Russian Federation, Poland, Ukraine, Serbia, the United States and the United Kingdom, among others.
Employees
6,005
Date Price Change Volume
18/08/26 €1.930 -0.26% 6,386
17/08/26 €1.935 -0.26% 30,136
14/08/26 €1.940 0.00% 5,750
13/08/26 €1.940 0.00% 4,110
12/08/26 €1.940 +0.78% 11,446

Annual profits - Rate of surprise